Westfield Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-750,604
| Closed | -$15M | – | 250 |
|
|
2018
Q2 | $15M | Buy |
750,604
+40,235
| +6% | +$804K | 0.11% | 194 |
|
|
2018
Q1 | $12.4M | Sell |
710,369
-90,000
| -11% | -$1.58M | 0.1% | 193 |
|
|
2017
Q4 | $19.7M | Sell |
800,369
-291,575
| -27% | -$7.19M | 0.15% | 186 |
|
|
2017
Q3 | $28.2M | Sell |
1,091,944
-157,310
| -13% | -$4.06M | 0.22% | 152 |
|
|
2017
Q2 | $33.9M | Buy |
1,249,254
+553,752
| +80% | +$15M | 0.29% | 120 |
|
|
2017
Q1 | $20.7M | Buy |
695,502
+247,287
| +55% | +$7.37M | 0.18% | 167 |
|
|
2016
Q4 | $12.2M | Buy |
+448,215
| New | +$12.2M | 0.11% | 205 |
|